Clinical Trials Directory

Trials / Completed

CompletedNCT05887050

Effects of a Dietary Supplement Containing Salacia Extract, Citrus Bioflavonoids, and Trivalent Chromium on Markers of Glucose Control

Effects of a Dietary Supplement Containing Salacia Extract, Citrus Bioflavonoids, and Trivalent Chromium on Markers of Glucose Control and Quality of Life: A Randomized, Placebo-Controlled, Double-Blind Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
The Center for Applied Health Sciences, LLC · Industry
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study was a double-blind, randomized, placebo-controlled, clinical trial with two parallel groups. Participants reported to a single investigational center in Ohio (i.e., The Center for Applied Health Sciences) during the 12 week trial.

Detailed description

This study was a double-blind, randomized, two-arm, placebo-controlled trial of apparently healthy men and women recruited at a single investigational center in Northeast Ohio (i.e. The Center for Applied Health Sciences). Subjects will attend four study visits. During Visit 1, subjects will be screened for participation (i.e., medical history, physical exam, routine blood work \[also HgA1c, insulin\], background baseline diet). Over the next 12 weeks, subjects will attend Visits 2-4, wherein assessments of serum glucose, insulin, HOMA-IR, 2-hour glucose tolerance test (GTT), NMR profile, HgA1c, C-reactive protein, adiponectin, ferritin, waist circumference, quality of life questionnaire, and various visual analog scales for appetite, satiety, and cravings will be made (see Study Schematic for details). Comprehensive side effect profile/ adverse event monitoring will take place throughout the study duration. The study will be conducted following ICH-GCP guidelines to ensure subject safety and scientific integrity of the data.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTActiveBlend of chromium, amla fruit extract, and citrus bioflavonoids
DIETARY_SUPPLEMENTPlaceboMaltodextrin tablet

Timeline

Start date
2020-12-03
Primary completion
2021-06-22
Completion
2021-07-20
First posted
2023-06-02
Last updated
2023-06-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05887050. Inclusion in this directory is not an endorsement.